{"id":1601,"date":"2018-05-25T17:16:02","date_gmt":"2018-05-25T16:16:02","guid":{"rendered":"https:\/\/www.groupactionlawyers.co.uk\/blog\/?p=1601"},"modified":"2018-05-25T17:16:02","modified_gmt":"2018-05-25T16:16:02","slug":"calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug","status":"publish","type":"post","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug","title":{"rendered":"Calls for UK inquiry into sodium valproate epilepsy drug"},"content":{"rendered":"<p>There are calls for a UK inquiry into the sodium valproate epilepsy drug that has been linked to birth defects and developmental issues in children.<\/p>\n<p>It\u2019s also understood that UK health professionals were warned about the dangers of people using sodium valproate epilepsy drugs, but little seems to have been done \u2013 especially in the past &#8211; to ensure users were informed of the risks and were able to make decisions as to the use of the drug.<\/p>\n<p>There are also questions over whether the drug should be classed as safe at all, and the HSE is reportedly looking at the issue. We may see a UK inquiry into the side-effects soon.<\/p>\n<p><!--more--><\/p>\n<p>There is already a <a href=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/sanofi-class-action-suit-over-epilepsy-drug-linked-birth-defects\" target=\"_blank\" rel=\"noopener\"><strong>huge class action in France over the use of sodium valproate epilepsy drugs against Sanofi<\/strong><\/a>. Our Group Action Lawyers have been tracking progress and are keeping an eye on the news as we remain vigilant over any potential UK class action cases that we may need to initiate. It\u2019s clear to us that <a href=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/sanofi-depakote-epilepsy-drug-caused-birth-defects-in-unborn-babies\" target=\"_blank\" rel=\"noopener\"><strong>greater warnings have been needed<\/strong><\/a> for women using the drug before or during pregnancy given the links to the birth defects and developmental issue.<\/p>\n<h2><strong>Our experience with medical group action cases<\/strong><\/h2>\n<p>Helping people claim in a class action case for medical negligence and medical product liability is one of our specialities. With a long history of representing large groups of individuals suffering because of a medical issue or medical product defect, we will be looking to take action for people and families who may be affected by the use of sodium valproate epilepsy drugs here in the UK.<\/p>\n<p>If you would like to share you story with us, we will look to advise you as best as we can, and where we feel there is a potential claim to initiate, we can help you.<\/p>\n<p>The developmental and infant deformities that have been reported as potentially linked to the use of sodium valproate epilepsy drugs lead to lifelong and serious suffering for the victims and their families. No one should ever suffer in silence: <a href=\"https:\/\/www.groupactionlawyers.co.uk\/contact\" target=\"_blank\" rel=\"noopener\"><strong>please don\u2019t hesitate to contact us for help.<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>There are calls for a UK inquiry into the sodium valproate epilepsy drug that has been linked to birth defects and developmental issues in children. It\u2019s also understood that UK health professionals were warned about the dangers of people using sodium valproate epilepsy drugs, but little seems to have been done \u2013 especially in the &hellip; <a href=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug\" class=\"more-link\">Continue reading <span class=\"screen-reader-text\">Calls for UK inquiry into sodium valproate epilepsy drug<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":1407,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[5,27],"tags":[60,24],"class_list":["post-1601","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical","category-products","tag-medical-product","tag-prescription-drugs"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Calls for UK inquiry into sodium valproate epilepsy drug - Group Action Lawyers<\/title>\n<meta name=\"description\" content=\"There are calls for a UK inquiry into the sodium valproate epilepsy drug that has been linked to birth defects and developmental issues in children.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Calls for UK inquiry into sodium valproate epilepsy drug - Group Action Lawyers\" \/>\n<meta property=\"og:description\" content=\"There are calls for a UK inquiry into the sodium valproate epilepsy drug that has been linked to birth defects and developmental issues in children.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug\" \/>\n<meta property=\"og:site_name\" content=\"Group Action Lawyers\" \/>\n<meta property=\"article:published_time\" content=\"2018-05-25T16:16:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i2.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pregnancy-epilepsy-drug-concerns.png?fit=1200%2C414&ssl=1\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"414\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Author\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Author\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug\"},\"author\":{\"name\":\"Author\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/0203ba576ea8f4e8ec318e9677b2a84b\"},\"headline\":\"Calls for UK inquiry into sodium valproate epilepsy drug\",\"datePublished\":\"2018-05-25T16:16:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug\"},\"wordCount\":361,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/pregnancy-epilepsy-drug-concerns.png?fit=1200%2C414&ssl=1\",\"keywords\":[\"medical product\",\"prescription drugs\"],\"articleSection\":[\"Medical\",\"Products\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug\",\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug\",\"name\":\"Calls for UK inquiry into sodium valproate epilepsy drug - Group Action Lawyers\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/pregnancy-epilepsy-drug-concerns.png?fit=1200%2C414&ssl=1\",\"datePublished\":\"2018-05-25T16:16:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/0203ba576ea8f4e8ec318e9677b2a84b\"},\"description\":\"There are calls for a UK inquiry into the sodium valproate epilepsy drug that has been linked to birth defects and developmental issues in children.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/pregnancy-epilepsy-drug-concerns.png?fit=1200%2C414&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/pregnancy-epilepsy-drug-concerns.png?fit=1200%2C414&ssl=1\",\"width\":\"1200\",\"height\":\"414\",\"caption\":\"pregnancy epilepsy drug concerns\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Calls for UK inquiry into sodium valproate epilepsy drug\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/\",\"name\":\"Group Action Lawyers\",\"description\":\"Latest Legal News, Articles &amp; Opinions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/0203ba576ea8f4e8ec318e9677b2a84b\",\"name\":\"Author\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g\",\"caption\":\"Author\"},\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/author\\\/matt\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Calls for UK inquiry into sodium valproate epilepsy drug - Group Action Lawyers","description":"There are calls for a UK inquiry into the sodium valproate epilepsy drug that has been linked to birth defects and developmental issues in children.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.groupactionlawyers.co.uk\/blog\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug","og_locale":"en_GB","og_type":"article","og_title":"Calls for UK inquiry into sodium valproate epilepsy drug - Group Action Lawyers","og_description":"There are calls for a UK inquiry into the sodium valproate epilepsy drug that has been linked to birth defects and developmental issues in children.","og_url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug","og_site_name":"Group Action Lawyers","article_published_time":"2018-05-25T16:16:02+00:00","og_image":[{"width":1200,"height":414,"url":"https:\/\/i2.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pregnancy-epilepsy-drug-concerns.png?fit=1200%2C414&ssl=1","type":"image\/png"}],"author":"Author","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Author","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug#article","isPartOf":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug"},"author":{"name":"Author","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/0203ba576ea8f4e8ec318e9677b2a84b"},"headline":"Calls for UK inquiry into sodium valproate epilepsy drug","datePublished":"2018-05-25T16:16:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug"},"wordCount":361,"commentCount":0,"image":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pregnancy-epilepsy-drug-concerns.png?fit=1200%2C414&ssl=1","keywords":["medical product","prescription drugs"],"articleSection":["Medical","Products"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.groupactionlawyers.co.uk\/blog\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug","url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug","name":"Calls for UK inquiry into sodium valproate epilepsy drug - Group Action Lawyers","isPartOf":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug#primaryimage"},"image":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pregnancy-epilepsy-drug-concerns.png?fit=1200%2C414&ssl=1","datePublished":"2018-05-25T16:16:02+00:00","author":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/0203ba576ea8f4e8ec318e9677b2a84b"},"description":"There are calls for a UK inquiry into the sodium valproate epilepsy drug that has been linked to birth defects and developmental issues in children.","breadcrumb":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.groupactionlawyers.co.uk\/blog\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug#primaryimage","url":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pregnancy-epilepsy-drug-concerns.png?fit=1200%2C414&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pregnancy-epilepsy-drug-concerns.png?fit=1200%2C414&ssl=1","width":"1200","height":"414","caption":"pregnancy epilepsy drug concerns"},{"@type":"BreadcrumbList","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/calls-for-uk-inquiry-into-sodium-valproate-epilepsy-drug#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.groupactionlawyers.co.uk\/blog"},{"@type":"ListItem","position":2,"name":"Calls for UK inquiry into sodium valproate epilepsy drug"}]},{"@type":"WebSite","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#website","url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/","name":"Group Action Lawyers","description":"Latest Legal News, Articles &amp; Opinions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.groupactionlawyers.co.uk\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/0203ba576ea8f4e8ec318e9677b2a84b","name":"Author","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/538ab826f4f2d4a28667f572267412a34ffb2abdd54a9fe5d344f0d525bf201f?s=96&d=mm&r=g","caption":"Author"},"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/author\/matt"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pregnancy-epilepsy-drug-concerns.png?fit=1200%2C414&ssl=1","jetpack-related-posts":[{"id":2304,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/sodium-valproate-claims-for-compensation","url_meta":{"origin":1601,"position":0},"title":"Sodium Valproate claims for compensation","author":"Author","date":"26th April 2022","format":false,"excerpt":"Sodium Valproate claims for compensation can be pursued for damages for any injury and suffering that has arisen from the use of the drug. The risks of using the drug during pregnancy can be significant and can lead to birth defects and serious developmental problems in infants. Unfortunately, consent and\u2026","rel":"","context":"In &quot;Group Actions&quot;","block_context":{"text":"Group Actions","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/group-actions"},"img":{"alt_text":"experts warn of buying diet pills online","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/buying-diet-pills-online-warning.png?fit=1200%2C414&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/buying-diet-pills-online-warning.png?fit=1200%2C414&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/buying-diet-pills-online-warning.png?fit=1200%2C414&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/buying-diet-pills-online-warning.png?fit=1200%2C414&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/buying-diet-pills-online-warning.png?fit=1200%2C414&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":1120,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/sanofi-class-action-suit-over-epilepsy-drug-linked-birth-defects","url_meta":{"origin":1601,"position":1},"title":"The class-action suit against Sanofi over epilepsy drug linked to birth defects","author":"Admin","date":"27th November 2017","format":false,"excerpt":"Thousands joined together to bring a class action case against French drug company Sanofi for allegedly not warning expectant mothers of the adverse side-effects of taking the epilepsy drug Depakine\/Depakote. French newspaper Le Canard Enchaine reported that over 10,000 pregnant women were given this drug between 2007 and 2014, and\u2026","rel":"","context":"In &quot;Medical&quot;","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"unborn babies at risk","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/12\/unborn-babies-at-risk.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/12\/unborn-babies-at-risk.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/12\/unborn-babies-at-risk.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/12\/unborn-babies-at-risk.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":1404,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/birth-defects-reportedly-caused-utero-exposure-epilepsy-drug","url_meta":{"origin":1601,"position":2},"title":"Birth defects reportedly caused by in-utero exposure to Epilepsy Drug","author":"Admin","date":"28th February 2018","format":false,"excerpt":"A drug that helps control epileptic seizures has been reportedly linked to birth defects and should not be used by pregnant women or women of child-bearing potential. Depakote was created by French pharmaceutical drug company Sanofi back in 1967. The British equivalent, Epilim, has been available since 1973. The drug\u2026","rel":"","context":"In &quot;Medical&quot;","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"pregnancy epilepsy drug concerns","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pregnancy-epilepsy-drug-concerns.png?fit=1200%2C414&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pregnancy-epilepsy-drug-concerns.png?fit=1200%2C414&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pregnancy-epilepsy-drug-concerns.png?fit=1200%2C414&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pregnancy-epilepsy-drug-concerns.png?fit=1200%2C414&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pregnancy-epilepsy-drug-concerns.png?fit=1200%2C414&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":333,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/sanofi-depakote-epilepsy-drug-caused-birth-defects-in-unborn-babies","url_meta":{"origin":1601,"position":3},"title":"Sanofi Depakote epilepsy drug that reportedly caused birth defects in 10,000 unborn babies","author":"Admin","date":"23rd December 2016","format":false,"excerpt":"Valproate Semisodium, better known as Depakote, has reportedly put more than 10,000 pregnant women at risk in France, and there are raising concerns that the same amount of women in the U.K. may also be affected by the epilepsy drug. Our Group Action Lawyers are investigating the issues, and anyone\u2026","rel":"","context":"In &quot;Latest&quot;","block_context":{"text":"Latest","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/latest"},"img":{"alt_text":"unborn babies at risk","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/12\/unborn-babies-at-risk.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/12\/unborn-babies-at-risk.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/12\/unborn-babies-at-risk.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/12\/unborn-babies-at-risk.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":770,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/sodium-cromoglicate-eye-drops-mhra-class-2-medicines-recall","url_meta":{"origin":1601,"position":4},"title":"MHRA publishes a class 2 Medicines recall for Sodium Cromoglicate eye drops","author":"Admin","date":"28th June 2017","format":false,"excerpt":"The Medicines and Health products Regulation Agency (MHRA) published a medical drug alert on the 18th May 2017 issuing a precautionary recall for bottles of eye drops amidst concerns that the solution can solidify in its container. Sodium Cromoglicate solution eye drops are typically used to treat red, watery and\u2026","rel":"","context":"In &quot;Medical&quot;","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"eye compensation","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/eye-drops-recall-min.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/eye-drops-recall-min.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/eye-drops-recall-min.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/eye-drops-recall-min.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":849,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/diclo-sr-75-pain-relief-tablets-class-2-recall","url_meta":{"origin":1601,"position":5},"title":"Class 2 recall for Diclo-SR 75 pain-relief tablets","author":"Admin","date":"28th July 2017","format":false,"excerpt":"A Watford-based pharmaceutical company has issued a voluntary recall for batches of Diclo-SR 75 pain relief tablets - AKA diclofenac sodium. The tablets are commonly used for pain relief and swelling for arthritis, musculoskeletal disorders, gout and pain caused by injury or minor surgery. The tablets are classified in a\u2026","rel":"","context":"In &quot;Medical&quot;","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"pain relief tablets recall","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/1601","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/comments?post=1601"}],"version-history":[{"count":1,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/1601\/revisions"}],"predecessor-version":[{"id":1602,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/1601\/revisions\/1602"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/media\/1407"}],"wp:attachment":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/media?parent=1601"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/categories?post=1601"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/tags?post=1601"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}